Array Technologies, Inc. (ARRY) Covered Calls

Array Technologies, Inc. covered calls Array BioPharma, Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of targeted small molecule drugs to treat patients afflicted with cancer, inflammatory and metabolic diseases.

You can sell covered calls on Array Technologies, Inc. to lower risk and earn monthly income. Born To Sell's covered call screener gives you customized search capabilities across all possible covered calls but here are a couple of examples for ARRY (prices last updated Tue 4:16 PM ET):

Array Technologies, Inc. (ARRY) Stock Quote
Last Change Bid Ask Volume P/E Market Cap
11.94 +0.25 11.84 11.92 5.6M 21 1.8
Covered Calls For Array Technologies, Inc. (ARRY)
Expiration Strike Call Bid Net Debit Return
If Flat		 Annualized
Return If Flat
May 17 12.5 0.85 11.07 7.7% 112%
Jun 21 12.5 1.20 10.72 11.2% 68.1%
Subscribers get access to the full covered call chain, and more features.

Want to make money with covered calls?  Sign Up For A Free Trial

Extended Business Description

Array BioPharma Inc. is a biopharmaceutical company, which focuses on the discovery, development, and commercialization of targeted small molecule drugs to treat patients afflicted with cancer. Its proprietary drug development pipeline focuses on the treatment of cancer and inflammatory disease and includes clinical candidates that are designed to regulate therapeutically important targets. It also collaborates with pharmaceutical and biotechnology companies under which the firm has out-licensed certain proprietary drug programs for further research, development, and commercialization. The company was founded by Kevin Koch, Anthony Piscopio, K.C. Nicolaou, and David L. Snitman in 1998 and is headquartered in Boulder, CO.